Literature DB >> 17695151

Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats.

Lalit Lakhwani1, Sudheer K Tongia, Veerendra S Pal, Rajendra P Agrawal, Prem Nyati, Pradeep Phadnis.   

Abstract

Forced swimming test is used to induce a characteristic behavior of immobility in rats, which resembles depression in humans to some extent. We evaluated the effect of omega-3 fatty acids alone as well as compared it with the standard antidepressant therapy with fluoxetine in both acute and chronic studies. In both the studies, rats were divided into 4 groups and subjected to the following drug interventions - Group 1- control: Group 2- fluoxetine in dose of 10 mg/kg subcutaneously 23.5, 5 and 1 h before the test: Group 3- omega-3 fatty acids in dose of 500 mg/kg orally; Group 4- fluoxetine plus omega-3 fatty acids both. In acute study, omega-3 fatty acids were given in single dose 2 h prior to the test while in chronic study omega-3 fatty acids were given daily for a period of 28 days. All animals were subjected to a 15-min pretest followed 24 h later by a 5-min test. A time sampling method was used to score the behavioral activity in each group. The results revealed that in acute study, omega-3 fatty acids do not have any significant effect in forced swimming test. However, in chronic study, omega-3 fatty acids affect the immobility and swimming behavior significantly when compared with control (p < 0.01) without any significant effect on climbing behavior and the efficacy of combination of omega-3 fatty acids and fluoxetine is significantly more than that of fluoxetine alone in changing the behavioral activity of rats in forced swimming test. It leads to the conclusion that omega-3 fatty acids have antidepressant activity per se, and the combination of fluoxetine and omega-3 fatty acids has more antidepressant efficacy than fluoxetine alone in forced swimming test in Wistar rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695151

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  16 in total

Review 1.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

2.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

3.  Combination of Omega 3 and Coenzyme Q10 Exerts Neuroprotective Potential Against Hypercholesterolemia-Induced Alzheimer's-Like Disease in Rats.

Authors:  Ghadha Ibrahim Fouad
Journal:  Neurochem Res       Date:  2020-03-02       Impact factor: 3.996

4.  N-3 PUFA Have Antidepressant-like Effects Via Improvement of the HPA-Axis and Neurotransmission in Rats Exposed to Combined Stress.

Authors:  Eun-Young Kim; Jeong-Eun Choi; Mijin Kim; Jisu Hong; Yongsoon Park
Journal:  Mol Neurobiol       Date:  2020-07-01       Impact factor: 5.590

5.  Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

Authors:  Robert K McNamara; Jennifer Strimpfel; Ronald Jandacek; Therese Rider; Patrick Tso; Jeffrey A Welge; Jeffrey R Strawn; Melissa P Delbello
Journal:  PharmaNutrition       Date:  2014-04-01

6.  Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.

Authors:  Robert K McNamara; Jessica A Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  Pharmacol Biochem Behav       Date:  2013-10-01       Impact factor: 3.533

7.  N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment.

Authors:  Beth Levant
Journal:  Depress Res Treat       Date:  2010-10-27

8.  Effects of omega-3 on behavioral and biochemical parameters in rats submitted to chronic mild stress.

Authors:  Aline Haas de Mello; Aline Gassenferth; Rosiane de Bona Schraiber; Luana da Rosa Souza; Drielly Florentino; Lucinéia Gainski Danielski; Evandro da Cruz Cittadin-Soares; Jucélia Jeremias Fortunato; Fabricia Petronilho; João Quevedo; Gislaine Tezza Rezin
Journal:  Metab Brain Dis       Date:  2014-06-26       Impact factor: 3.584

9.  Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.

Authors:  Jessica A Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

Review 10.  N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence.

Authors:  Beth Levant
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-06       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.